NCT06530212 Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass
| NCT ID | NCT06530212 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Minia University |
| Condition | Obesity, Morbid |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-09-28 |
| Primary Completion | 2025-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-09-28 with a primary completion date of 2025-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
sleeve gastrectomy with jejunoileal bypass (SGJIB) is a novel technique for the surgical treatment of obesity. The aim of the study is to compare this maneuver with single anastomosis sleeve jejunal bypass (SAS-JB)
Eligibility Criteria
Inclusion Criteria: * obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity * patients fit for laparoscopic surgery * give approval to share in the study Exclusion Criteria: * patients refused to share in the study * patients unfit for surgery * patients aged less than 18 and older than 60 * patient with previous upper abdominal surgery either for obesity or other diseases * revisional bariatric procedures
Contact & Investigator
Alaa Sewefy, professor
PRINCIPAL INVESTIGATOR
Minia University
Frequently Asked Questions
Who can join the NCT06530212 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06530212 currently recruiting?
Yes, NCT06530212 is actively recruiting participants. Contact the research team at sewafy@yahoo.co.uk for enrollment information.
Where is the NCT06530212 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT06530212 clinical trial?
NCT06530212 is sponsored by Minia University. The principal investigator is Alaa Sewefy, professor at Minia University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.